Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1Phase 1 1

Status

Completed 23Terminated 6Recruiting 5Active not recruiting 5Unknown 2Withdrawn 1Available 1

Sponsor Class

OTHER 3INDUSTRY 2NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 36Gastrointestinal 16Breast 9Sarcoma 6Dermatologic 4CNS 4Other hematologic neoplasm 3Lymphoid 3Tumor-Agnostic 2Thoracic 2Other solid neoplasm 2NET 2Myeloid 2Head & Neck 2Endocrine 2Plasma cell 1Classical hematology 1

Conditions

Gastrointestinal Stromal Tumors 4Sarcoma 1Neoplasms 1Gliosarcoma 1Brain Neoplasms 1

Interventions

Cyclophosphamide 26Temozolomide 23Doxorubicin 22Radiotherapy 21Filgrastim 19Ifosfamide 15pazopanib 14Gemcitabine 14Etoposide 13Bevacizumab 13Irinotecan 12Cisplatin 12Magnetic Resonance Spectroscopy 11Imatinib Mesylate 11Granulocyte Colony-Stimulating Factor 11Carboplatin 11Radiation 9Methotrexate 9pembrolizumab 8fludarabine phosphate 8Rituximab 8Paclitaxel 8Docetaxel 8Cyclosporine 8Busulfan 8Antilymphocyte Serum 8fludarabine 7Vincristine 7Radiotherapy, Intensity-Modulated 7Mycophenolic Acid 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Terminated × Sunitinib × Sarcoma × Clear all
NCT04409223 2024-02-09

Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Terminated
185 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03641326 2022-04-19

Sunitinib in Sarcomas of the Central Nervous System

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
5 enrolled 14 charts
CNSSarcoma

Brain Neoplasms, Gliosarcoma

NCT00859456 2019-11-04

Sunitinib in Certain Subtypes of Soft Tissue Sarcomas

Columbia University

Phase 2 Terminated
10 enrolled 6 charts
Sarcoma

Sarcoma

NCT01054911 2016-09-22

Evaluation of Patients With Bulky GIST Using Sunitinib

University of Alabama at Birmingham

Phase NA Terminated
5 enrolled 4 charts
GastrointestinalSarcoma

Neoplasms, Gastrointestinal Stromal Tumors

NCT00573404 2011-11-16

Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors

Vanderbilt-Ingram Cancer Center

Phase 1 Terminated
6 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00372567 2011-03-17

Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors

Pfizer

Phase 3 Terminated
69 enrolled 22 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡